Global Point of Care Blood Gas and Electrolyte Market Information, By Product Type (Consumables and Instruments), By End Users (Hospitals & Clinics, and Research Institute) - Global Forecast till 2027
ID: MRFR/MED/3649-CR | November 2017 | Region: Global | 76 pages
Market Scenario:
Point of care blood gas and electrolyte analyzers helps to measure different parameters of whole blood samples, such as blood gas (pCO2 and pO2), pH, and electrolytes. It is one of the innovative concepts that is introduced in the field of critical care settings to deliver decentralized, patient-centric health care to the patients. These devices are playing an important role in the field of healthcare and help in reducing therapeutic turnaround time, enhance patient satisfaction, accuracy, and quick test, and help to improve hospital operations. This new technology provides smaller handheld devices with advancements in diagnostic sensors.
Point of care blood gas and electrolyte devices are used majorly in the area of hospitals where patients are being ventilated. Increase in the treatments in NICUs, ICUs, Cardiovascular Operating Room (CVOR), and emergency department has boosted the point of care blood gas and electrolyte devices market growth. Additionally, rising prevalence of chronic diseases and cancer fuels the market growth.
According to the Centers for Disease Control and Prevention, in 2015, the number of adults with diagnosed chronic bronchitis and emphysema were 9.3 million and 3.5 million respectively. Additionally, according to WHO in 2016, over 1.9 billion adults aged 18 years and older were obese, which was approximately 650 million. Overall 13% of world’s adult population (11% of men and 15% of women) were obese. These diseases are the main cause of the immense growth of treatment in NICUs, ICUs, Cardiovascular Operating Room (CVOR), and emergency department. Point of care blood gas developers is now focusing on developing automated and user-friendly devices, which may lead the market of this product in the coming future. Healthcare expenditure across the world is rapidly increasing. From the last decade, healthcare expenditure in regions like the Americas and Europe has been growing rapidly. According to the Centers for Medicare & Medicaid Services, in 2015, the U.S. healthcare spending was increased by 5.8% and reached USD 3.2 trillion.
The market is expected to grow at a CAGR of 7.8% during the forecast period and is estimated to cross USD 2,543.1 million by 2023.
Figure- Global POC blood gas and electrolyte, by product end user 2016 (%) 
Source: Annual reports, company presentation, World Health Organization, American Laboratory, Global Initiative for Chronic Obstructive Lung Disease, Centers for Disease Control and Prevention, National Center for Biotechnology Information, Company Website, and MRFR Analysis.
Intended Audience:
- POC blood gas & electrolyte devices manufacturers
- POC blood gas & electrolyte devices suppliers
- Medical research laboratories
- Research and development (R&D) companies
- Market research and consulting service providers
- Potential investors
Research Methodology: 
Source: Annual reports, company presentation, World Health Organization, American Laboratory, Global Initiative for Chronic Obstructive Lung Disease, Centers for Disease Control and Prevention, National Center for Biotechnology Information, Company Website, and MRFR Analysis.
Segments:
The global POC blood gas and electrolyte devices market has been segmented on the basis of types and end users.
On the basis of the types, the market is segmented into consumables and Instruments. Furthermore, the instrument is segmented into benchtop and portable devices. The consumable devices are further segmented into reagents, cartridges, and others.
On the basis of end users, the market is segmented into hospitals & clinics, home care, research institutions, and others.
Regional analysis:
Considering the global scenario of the market, the Americas dominates the global point of care blood gas and electrolyte market owing to the presence of a huge patient population with a chronic diseases like diabetes, kidney and liver disease and increasing government support for research & development. Additionally, concentration of leading players in this region accounts for the major share of the global market. According to Centers for Disease Control and Prevention (CDC), 30.3 million people of all age group of the U. S. population diagnosed with diabetes in 2015. Rapidly rising diabetic patient population increases the footfall in hospitals, and create the immense demands for POC blood gas and electrolyte devices.
Europe is the second largest market, which is followed by Asia Pacific owing to the presence of well-developed healthcare sector, strong government support for research & development and high healthcare expenditure. Regionally, Europe is divided into Germany, France, the U.K, Italy, Spain, and Rest of Western Europe. Germany and the U.K are the major contributors to the European market growth.
Asia Pacific is also witnessing a rapid growth in this market due to rapidly increasing diabetic & obese population and rising healthcare expenditure. According to the WHO, 60% of world’s total diabetic population lives in Asia Pacific region. Additionally, the presence of rapidly developing economies like India and China likely to fuel the market growth over the forecast period.
The Middle East & Africa hold the least share of the market due to poor political conditions in Africa, and limited availability of funds and medical facilities. The Middle East holds the major share of the Middle East & Africa region due to the presence of well-developed countries like Kuwait, Qatar, Oman, and Saudi Arabia. Whereas, African region is expecting a healthy growth due to the presence of a huge opportunity for the development of the market during the review period.
Key Findings:
- Consumables product segment accounts for the largest market share of 61.5% while the instruments segment is projected to grow at a CAGR of 6.3% during the forecast period from 2017 – 2023
- Hospitals & clinics dominates the global POC blood gas and electrolyte market with nearly 58.4% share of the global market, by end users
- Americas POC blood gas and electrolyte market is estimated to be USD 600.2 million in 2016
Key players:
Some of the major players in this market are Siemens, Abbott, F. Hoffman-La Roche Ltd., Radiometer, Nova medical, Edan Instruments Inc., and Instrumentation Laboratory.
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size |
|
| CAGR | 7.8% (2014-2023) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Types and End Users |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Siemens, Abbott, F. Hoffman-La Roche Ltd., Radiometer, Nova medical, Edan Instruments Inc., and Instrumentation Laboratory |
| Key Market Opportunities | New product launches and R&D Amongst major key Players |
| Key Market Drivers | Rising prevalence of chronic diseases and cancer |
Frequently Asked Questions (FAQ) :
point of care blood gas and electrolyte market is projected to grow at a 7.8% CAGR between 2020-2027.
point of care blood gas and electrolyte market predicted to touch USD 2,543.1 million by 2023.
The Americas is projected to dominate the point of care blood gas and electrolyte market.
Key players profiled in the point of care blood gas and electrolyte market include Instrumentation Laboratory, Edan Instruments Inc., Nova medical, Radiometer, F. Hoffman-La Roche Ltd., Abbott, and Siemens.
Hospitals and clinics will dominate the point of care blood gas and electrolyte market.
1 Report Prologue
2 Market Introduction
2.1 Scope Of Study 12
2.2 Research Objective 12
2.3 Assumptions & Limitations 13
2.3.1 Assumptions 13
2.3.2 Limitations 13
2.4 Market Structure 13
3 Research Methodology
3.1 Research Process 14
3.2 Primary Research 15
3.3 Secondary Research 15
3.4 Market Size Estimation 15
3.5 Forecast Model 16
4 Market Dynamics
4.1 Drivers 17
4.1.1 Increasing Prevalence Of Respiratory Acidosis (Weightage 40%) 17
4.1.2 Increasing Prevalence Of Various Disorders (Weightage 60%) 18
4.2 Restraints 19
4.2.1 Analyser Inaccuracy, Imprecision, And Performance (Impact Weightage 55%) 19
4.2.2 High Cost Of Devices And Regulatory Framework (Impact Weightage 45%) 20
4.3 Opportunity 21
4.4 Mega Trends 21
4.5 Macroeconomic Indicators 21
4.6 Technological Trends 22
5 Market Factor Analysis
5.1 Value Chain Analysis 23
5.1.1 Research & Product Development 23
5.1.2 Component Manufacturing 23
5.1.3 Assembly 24
5.1.4 Distribution & Sales 24
5.2 Porters Five Forces Model 25
5.2.1 Bargaining Power Of Suppliers 25
5.2.2 Bargaining Power Of Buyers 26
5.2.3 Threat Of New Entrants 26
5.2.4 Threat Of Substitutes 26
5.2.5 Intensity Of Rivalry 26
5.3 Demand & Supply – Gap Analysis 26
5.4 Pricing Analysis 27
5.5 Investment Opportunities 27
6 Global POC Blood Gas & Electrolyte, Product
6.1 Introduction 28
6.1.1 Consumables 30
6.1.2 Instruments 30
7 Global POC Blood Gas & Electrolyte, End User
7.1 Introduction 31
7.1.1 Hospitals & Clinics 32
7.1.2 Research Institutions 32
8 Global POC Blood Gas & Electrolyte, Region
8.1 Introduction 34
8.2 Americas 36
8.2.1 North America 37
8.2.1.1 U.S. 38
8.2.1.2 Canada 39
8.2.2 South America 40
8.3 Europe 42
8.3.1 Western Europe 43
8.3.1.1 Germany 44
8.3.1.2 France 45
8.3.1.3 U.K. 46
8.3.1.4 Italy 47
8.3.1.5 Spain 48
8.3.1.6 Rest Of Western Europe 49
8.3.2 Eastern Europe 50
8.4 Asia-Pacific 52
8.4.1 Japan 53
8.4.2 China 54
8.4.3 India 55
8.4.4 Republic Of Korea 56
8.4.5 Australia 57
8.4.6 Rest Of Asia-Pacific 58
8.5 Middle East & Africa 60
8.5.1 Middle East 61
8.5.2 Africa 62
9 Company Landscape
9.1 Company Share Analysis 64
10 Company Profile
10.1 Siemens 66
10.1.1 Company Overview 66
10.1.2 Financials 66
10.1.3 Products 66
10.1.4 Strategy 66
10.1.5 Key Developments 66
10.2 Abbott 67
10.2.1 Company Overview 67
10.2.2 Financials 67
10.2.3 Products 67
10.2.4 Strategy 67
10.2.5 Key Developments 67
10.3 F. Hoffman-La Roche Ltd 68
10.3.1 Company Overview 68
10.3.2 Financials 68
10.3.3 Products 68
10.3.4 Strategy 68
10.3.5 Key Developments 68
10.4 Radiometer 69
10.4.1 Company Overview 69
10.4.2 Financials 69
10.4.3 Products 69
10.4.4 Strategy 69
10.4.5 Key Developments 69
10.5 Nova Biomedical 70
10.5.1 Company Overview 70
10.5.2 Financials 70
10.5.3 Products 70
10.5.4 Strategy 70
10.5.5 Key Developments 70
10.6 Edan Instruments Inc 71
10.6.1 Company Overview 71
10.6.2 Financials 71
10.6.3 Products 71
10.6.4 Strategy 71
10.6.5 Key Developments 71
10.7 Instrumentation Laboratory 72
10.7.1 Company Overview 72
10.7.2 Financials 72
10.7.3 Products 72
10.7.4 Strategy 72
10.7.5 Key Developments 72
11 MRFR Conclusion
11.1 Key Findings 73
11.1.1 From CEO’s View Point 73
11.1.2 Unmet Needs 73
11.2 Key Companies To Watch 73
11.2.1 Prediction 74
12 Appendix
12.1 Discussion Blue Print 75
12.2 References 76
13 List Of Tables
TABLE 1 GLOBAL POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 29
TABLE 2 GLOBAL CONSUMABLES MARKET, BY REGION 2020-2027 (USD MILLION) 30
TABLE 3 GLOBAL INSTRUMENTS MARKET, BY REGION 2020-2027 (USD MILLION) 30
TABLE 4 GLOBAL POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 32
TABLE 5 GLOBAL HOSPITALS & CLINICS MARKET, BY REGION 2020-2027 (USD MILLION) 32
TABLE 6 GLOBAL RESEARCH INSTITUTIONS MARKET, BY REGION 2020-2027 (USD MILLION) 32
TABLE 7 GLOBAL POC BLOOD GAS AND ELECTROLYTE MARKET, BY REGION 2020-2027 (USD MILLION) 35
TABLE 8 AMERICAS POC BLOOD GAS AND ELECTROLYTE MARKET, BY REGION 2020-2027 (USD MILLION) 36
TABLE 9 AMERICAS POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 36
TABLE 10 AMERICAS POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 37
TABLE 11 NORTH AMERICA POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 37
TABLE 12 NORTH AMERICA POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 38
TABLE 13 U.S. POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 38
TABLE 14 U.S. POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 39
TABLE 15 CANADA POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 39
TABLE 16 CANADA POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 40
TABLE 17 SOUTH AMERICA POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 40
TABLE 18 SOUTH AMERICA POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 41
TABLE 19 EUROPE POC BLOOD GAS AND ELECTROLYTE MARKET, BY REGION 2020-2027 (USD MILLION) 42
TABLE 20 EUROPE POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 42
TABLE 21 EUROPE POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 43
TABLE 22 WESTERN EUROPE POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 43
TABLE 23 WESTERN EUROPE POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 44
TABLE 24 GERMANY POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 44
TABLE 25 GERMANY POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 45
TABLE 26 FRANCE POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 45
TABLE 27 FRANCE POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 46
TABLE 28 U.K. POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 46
TABLE 29 U.K. POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 47
TABLE 30 ITALY POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 47
TABLE 31 ITALY POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 48
TABLE 32 SPAIN POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 48
TABLE 33 SPAIN POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 49
TABLE 34 REST OF WESTERN EUROPE POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 49
TABLE 35 REST OF WESTERN EUROPE POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 50
TABLE 36 EASTERN EUROPE POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 50
TABLE 37 EASTERN EUROPE POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 51
TABLE 38 ASIA-PACIFIC POC BLOOD GAS AND ELECTROLYTE MARKET, BY COUNTRIES 2020-2027 (USD MILLION) 52
TABLE 39 ASIA-PACIFIC POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 52
TABLE 40 ASIA-PACIFIC POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 53
TABLE 41 JAPAN POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 53
TABLE 42 JAPAN POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 54
TABLE 43 CHINA POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 54
TABLE 44 CHINA POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 55
TABLE 45 INDIA POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 55
TABLE 46 INDIA POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 56
TABLE 47 REPUBLIC OF KOREA POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 56
TABLE 48 REPUBLIC OF KOREA POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 57
TABLE 49 AUSTRALIA POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 57
TABLE 50 AUSTRALIA POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 58
TABLE 51 REST OF ASIA-PACIFIC POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 58
TABLE 52 REST OF ASIA-PACIFIC POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 59
TABLE 53 MIDDLE EAST & AFRICA POC BLOOD GAS AND ELECTROLYTE MARKET, BY REGION 2020-2027 (USD MILLION) 60
TABLE 54 MIDDLE EAST & AFRICA POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 60
TABLE 55 MIDDLE EAST & AFRICA POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 61
TABLE 56 MIDDLE EAST POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 61
TABLE 57 MIDDLE EAST POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 62
TABLE 58 AFRICA POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020-2027 (USD MILLION) 62
TABLE 59 AFRICA POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020-2027 (USD MILLION) 63
14 List Of Figures
FIGURE 1 GLOBAL POC BLOOD GAS AND ELECTROLYTE MARKET: MARKET STRUCTURE 13
FIGURE 2 RESEARCH PROCESS 14
FIGURE 3 GLOBAL POC BLOOD GAS AND ELECTROLYTE MARKET: FORECAST MODEL 16
FIGURE 4 VALUE CHAIN: POC BLOOD GAS AND ELECTROLYTE DEVICES MARKET 23
FIGURE 5 PORTERS FIVE FORCES MODEL 25
FIGURE 6 GLOBAL POC BLOOD GAS AND ELECTROLYTE MARKET, BY PRODUCT 2020 & 2027 (USD MILLION) 29
FIGURE 7 GLOBAL POC BLOOD GAS AND ELECTROLYTE MARKET, BY END USER 2020 & 2027 (USD MILLION) 31
FIGURE 8 GLOBAL POC BLOOD GAS AND ELECTROLYTE MARKET, BY REGION 2020 & 2027 (USD MILLION) 35
FIGURE 9 GLOBAL POC BLOOD GAS AND ELECTROLYTE COMPANY SHARE ANALYSIS, 2020 (%) 64